The Genomic Landscape a nd Clinical Relevance of A-toI RNA Editing in Human Cancers Graphical

[1]  Eli Eisenberg,et al.  Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors. , 2015, Cell reports.

[2]  David Gacquer,et al.  Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome , 2015, bioRxiv.

[3]  E. Eisenberg,et al.  Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma , 2015, Genome Biology.

[4]  Yiling Lu,et al.  Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors. , 2014, Cancer cell.

[5]  Seung-Yong Jeong,et al.  RNA editing in RHOQ promotes invasion potential in colorectal cancer , 2014, The Journal of experimental medicine.

[6]  Eli Eisenberg,et al.  A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes , 2014, Genome research.

[7]  Yan Li,et al.  Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. , 2014, Cancer research.

[8]  Jin Billy Li,et al.  RADAR: a rigorously annotated database of A-to-I RNA editing , 2013, Nucleic Acids Res..

[9]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[10]  Adam A. Margolin,et al.  Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas , 2013, Nature Genetics.

[11]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[12]  The Cancer Genome Atlas Research Network.  COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.

[13]  Kol Jia Yong,et al.  A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma , 2013, Gut.

[14]  Gideon Rechavi,et al.  MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. , 2013, The Journal of clinical investigation.

[15]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[16]  Jin Billy Li,et al.  Edinburgh Research Explorer Identifying Rna Editing Sites Using Rna Sequencing Data Alone , 2022 .

[17]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[18]  Zhiyu Peng,et al.  Lack of evidence for existence of noncanonical RNA editing , 2013, Nature Biotechnology.

[19]  Vladimir N Uversky,et al.  Hypothesis , 2013, Intrinsically Disordered Proteins.

[20]  R. Boldrini,et al.  ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis , 2012, Oncogene.

[21]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[22]  Jessica M. Rusert,et al.  ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia , 2012, Proceedings of the National Academy of Sciences.

[23]  Li Ding,et al.  Somatic Mutations of PIK3R1 Promote Gliomagenesis , 2012, PloS one.

[24]  G. Mills,et al.  Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer , 2012, Genome research.

[25]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[26]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[27]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[28]  Jin Billy Li,et al.  Accurate identification of human Alu and non-Alu RNA editing sites , 2012, Nature Methods.

[29]  Matthew A. Hibbs,et al.  Canonical A-to-I and C-to-U RNA Editing Is Enriched at 3′UTRs and microRNA Target Sites in Multiple Mouse Tissues , 2012, PloS one.

[30]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[31]  Wenwei Zhang,et al.  Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome , 2012, Nature Biotechnology.

[32]  Jae-Hyung Lee,et al.  Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. , 2012, Genome research.

[33]  Mingyao Li,et al.  Widespread RNA and DNA Sequence Differences in the Human Transcriptome , 2011, Science.

[34]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[35]  Mats Ensterö,et al.  Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. , 2009, Genome research.

[36]  Izumi V. Hinkson,et al.  RNA Editing of Androgen Receptor Gene Transcripts in Prostate Cancer Cells* , 2008, Journal of Biological Chemistry.

[37]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[38]  M. O’Connell,et al.  Down-regulation of RNA Editing in Pediatric Astrocytomas , 2008, Journal of Biological Chemistry.

[39]  T. Mikkelsen,et al.  Altered adenosine-to-inosine RNA editing in human cancer. , 2007, Genome research.

[40]  L. Landweber,et al.  Hypothesis: RNA editing of microRNA target sites in humans? , 2007, RNA.

[41]  A. Hatzigeorgiou,et al.  Redirection of Silencing Targets by Adenosine-to-Inosine Editing of miRNAs , 2007, Science.

[42]  A. MacMillan,et al.  FRET Analysis of in Vivo Dimerization by RNA-editing Enzymes* , 2006, Journal of Biological Chemistry.

[43]  John M. Murray,et al.  Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNA* , 2003, The Journal of Biological Chemistry.

[44]  Brenda L Bass,et al.  RNA editing by adenosine deaminases that act on RNA. , 2002, Annual review of biochemistry.

[45]  M Schrey,et al.  Underediting of glutamate receptor GluR-B mRNA in malignant gliomas , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. O’Connell,et al.  The many roles of an RNA editor , 2001, Nature Reviews Genetics.

[47]  A. Rich,et al.  Changing genetic information through RNA editing , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[48]  K. Nishikura,et al.  A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. , 2000, RNA.

[49]  T. Dawson,et al.  Regulation of alternative splicing by RNA editing , 1999, Nature.

[50]  P. Seeburg,et al.  A standardized nomenclature for adenosine deaminases that act on RNA. , 1997, RNA.

[51]  P. Seeburg,et al.  Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Seeburg,et al.  RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency , 1993, Cell.